Breaking News
Sort by:
Top Post
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial
Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% […]
Half a Million COVID Jabs Booked in ‘Glastonbury Rush’ This Morning
The NHS saw a welcome surge in demand for vaccines this morning as half a […]
Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today […]
Oxford/AstraZeneca Alternative Now Available at Riverside Vaccination Centre
Vaccination appointments are available for residents who are eligible at the Riverside Vaccination Centre in […]
‘We Can Treat It’: Mortality Rate of Rare Condition Linked to AstraZeneca Shot Plunges
Doctors are now confident they can detect and treat the rare blood clotting syndrome associated […]
EU Digital COVID Certificate: EU Gateway Goes Live with Seven Countries One Month Ahead of Deadline
Today, the EU Digital COVID Certificate has reached another important milestone with the go-live of the technical […]
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C […]
Government and Life Science Industry Join Forces on 100 Days Mission for Future Pandemics
Life science industry leaders are joining forces with governments to step up collective efforts to […]
The MHRA Concludes Positive Safety Profile for Pfizer/BioNTech Vaccine in 12- to 15-year-olds
An extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its […]
The Bill & Melinda Gates Foundation Pledges $50 Million to Increase Access to Safe and Affordable COVID-19 Vaccines in Lower-income Countries
The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more